Innate Pharma Stock
Innate Pharma Stock
The Innate Pharma stock is trending slightly upwards today, with an increase of €0.002 (0.130%) compared to yesterday's price.
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 0.130% | -1.299% | -10.272% | -13.930% | -0.654% | -42.964% | -46.441% |
| Nanobiotix | 0.120% | 0.416% | -5.593% | 477.094% | 76.754% | 407.669% | 191.286% |
| Poxel S.A. | -2.170% | 0.101% | -1.683% | -61.808% | -16.904% | -65.521% | -96.531% |
| Adocia | 0.100% | 1.148% | -4.880% | -38.295% | -38.576% | -28.877% | -57.815% |
